Back to Rankings

CGEM

Cullinan TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
Current thesis
Cullinan has multiple near-term binary value catalysts: CLN-978 autoimmune readouts, zipalertinib's FDA review, and CLN-049/velinotamig follow-through. Q1 also showed $393.3m cash/investments and runway into 2029, reducing financing pressure, while the June 8 8-K's improvement in disease-activity labs gives the autoimmune program a positive early read [#PR-EARNINGS-2026-05-07] [#SEC-8K-2026-05-07] [#8-K-2026-06-08].
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -3.8.
What can break
CLN-049 remains early-stage and needs more data before a registrational path is credible; tolerability or efficacy could fall short.
Momentum
88
Value
41
Sentiment
27
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $13.50 · Bull $30.00 · Bear $6.50
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-10 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $32.75
Why
Momentum88 · Δ7d -3.8
Value41 · Δ7d +0.1
Sentiment27 · Δ7d -0.1
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
88
26% active weight
Current posture
7d trendSoftening
Δ7d
-3.8
Δ21d
+11.1
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.0
Sentiment
27
34% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.8
Why this grade

Composite grade D. Momentum 87.7 / Value 41.1 / Sentiment 26.8

Fundamentals (TTM)
As of 2026-07-21
Market Cap
$1.11B
Beta
-0.09
Shares Out
61.94M
P/E (TTM) · Derived
-4.8
P/S (TTM)
-
P/FCF (TTM) · Derived
-6.06
Rev YoY
-100.0%
EPS YoY
-1.2%
Gross Margin
-
Op Margin
-
Net Debt
-$375.21M
Current Ratio
10.28
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology